Related Experiment Video
Updated: Aug 4, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
The impact of liver dysfunction on outcome in patients with multiple injuries
B G Harbrecht1, H R Doyle, K D Clancy
1Department of Surgery, University of Pittsburgh, Pennsylvania, USA.
Abstract:
Multiple organ dysfunction syndrome (MODS) is the leading cause of late deaths after traumatic injury. The relative importance of dysfunction of individual organ systems in determining outcome from MODS has not been clearly defined. Some studies have suggested that hepatic dysfunction associated with MODS increases mortality, whereas others have suggested that it contributes little to outcome in trauma patients. To clarify the role of the hepatic dysfunction after traumatic injury we retrospectively reviewed all trauma patients with an Injury Severity Score > or = 14 admitted from January 1, 1994 through June 30, 1997 for the presence of hepatic dysfunction defined as a serum bilirubin > or = 2.0 mg/dL. Of the 1962 patients who met the entry criteria 154 developed hepatic dysfunction during their hospital stay. Patients with hepatic dysfunction were older (46 +/- 2 versus 41 +/- 1 years), were more severely injured (Injury Severity Score 31.5 +/- 0.9 versus 23.3 + 0.2), and had a lower prehospital blood pressure (102 +/- 3 versus 117 +/- 1 mm Hg) compared with patients who did not develop hepatic dysfunction. Patients with hepatic dysfunction were more likely to present with shock as reflected in a lower initial emergency room blood pressure (109 +/- 3 versus 128 +/- 1 mm Hg) and base deficit (-6.9 +/- 0.6 versus -3.5 +/- 0.1 mEq/L). Patients who developed hyperbilirubinemia had longer lengths of stay in the intensive care unit (15.8 +/- 1.2 versus 3.4 +/- 0.2 days) and the hospital (27.4 +/- 1.7 versus 11.1 +/- 0.2 days) and a higher in-hospital mortality (16.2% versus 2.5%). These data demonstrate that the development of hepatic dysfunction reflects the severity of injury and is associated with a significantly worse outcome after traumatic injury.
Insights
Hepatic dysfunction, indicated by elevated bilirubin, is common in severe trauma patients. This organ dysfunction significantly worsens outcomes, increasing mortality and hospital stay duration.
Area of Science:
- Trauma Surgery
- Critical Care Medicine
- Hepatology
Background:
- Multiple organ dysfunction syndrome (MODS) is a primary cause of mortality following traumatic injuries.
- The specific impact of hepatic dysfunction on MODS outcomes in trauma patients remains debated.
- Clarifying the role of liver dysfunction is crucial for improving patient management.
Purpose of the Study:
- To investigate the association between hepatic dysfunction and patient outcomes after traumatic injury.
- To determine if elevated serum bilirubin levels correlate with increased mortality and resource utilization in trauma patients.
Main Methods:
- Retrospective review of 1962 trauma patients with Injury Severity Score >= 14.
- Hepatic dysfunction defined as serum bilirubin >= 2.0 mg/dL.
- Comparison of demographic, injury severity, and outcome data between patients with and without hepatic dysfunction.
Main Results:
- 154 patients (7.8%) developed hepatic dysfunction.
- Patients with hepatic dysfunction were older, had higher injury severity scores, and presented with signs of shock (lower blood pressure, base deficit).
- Hepatic dysfunction was linked to significantly longer intensive care unit and hospital stays, and a higher in-hospital mortality rate (16.2% vs. 2.5%).
Conclusions:
- Development of hepatic dysfunction in trauma patients reflects injury severity.
- Hepatic dysfunction is a significant independent predictor of worse outcomes, including increased mortality and prolonged hospitalization.
- These findings underscore the importance of monitoring liver function in severe trauma patients.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Acute Kidney Injury III: Clinical Manifestations
Cirrhosis II: Pathophysiology

